IPAD-DB ID | C00314 |
Name | Radicinin |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 2 H 1 2 O 5 |
Molecular Weight | 236.22g/mol |
IUPAC Name | (2S, 3S)-3-hydroxy-2-methyl-7-[(E)-prop-1-enyl]-2, 3-dihydropyrano[3, 2-c]pyran-4, 5-dione |
InChI | InChI=1S/C12H12O5/c1-3-4-7-5-8-9(12(15)17-7)11(14)10(13)6(2)16-8/h3-6, 10, 13H, 1-2H3/b4-3+/t6-, 10-/m0/s1 |
InChIKey | SDKXGAICTNHFCN-DCJAWTJCSA-N |
Canonical SMILES | CC=CC1=CC2=C(C(=O)C(C(O2)C)O)C(=O)O1 |
PubChem CID | 5381458 |
DrugBank Accession Number | - |
CAS Registry Number | 10088-95-6 |
Molecular Weight(Computed by SwissADME) | 236.22 |
Hac(Computed by SwissADME) | 17 |
Volume(Computed by ADMETlab 2.0) | 229.764 |
Density(Computed by ADMETlab 2.0) | 1.027 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 10 |
nHet(Computed by ADMETlab 2.0) | 5 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 14 |
Flexibility(Computed by ADMETlab 2.0) | 0.071 |
Stero Centers(Computed by ADMETlab 2.0) | 2 |
LogS(Computed by ADMETlab 2.0) | -2.221 |
LogD(Computed by ADMETlab 2.0) | 0.626 |
logP(Computed by ADMETlab 2.0) | 0.93 |
TPSA(Computed by SwissADME) | 76.74 |
Hbond Acceptor(Computed by SwissADME) | 5 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.99 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |